Arch Venture Partners Ix, Llc Karuna Therapeutics, Inc. (KRTX) insider trading activity

Arch Venture Partners Ix, LLC is > 10% Shareholder of Karuna Therapeutics, Inc.. Currently has a direct ownership of 918 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Apr 13, 2021, when has been sold 1,264 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 918

0% 3M change

0% 12M change

Total Value Held $0

ARCH Venture Partners IX, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 13 2021	BUY Other acquisition or disposition	-	1,264 Added 57.93%	918 Common Stock
Jan 08 2021	BUY Other acquisition or disposition	-	1,264 Added 67.38%	612 Common Stock
Nov 12 2020	BUY Other acquisition or disposition	-	1,264 Added 80.51%	306 Common Stock

Also insider at

BEAM

Beam Therapeutics Inc. Healthcare

> 10% Shareholder

VIR

Vir Biotechnology, Inc. Healthcare

> 10% Shareholder

LYEL

Lyell Immunopharma, Inc. Healthcare

> 10% Shareholder

AVP